Perrigo Company
PRGO • NYSE
Perrigo Company is a drug manufacturers - specialty & generic company in the healthcare sector trading on NYSE, led by CEO Patrick Lockwood-Taylor, with a market cap of $1.6B.
Market Cap$1.6B
CEOPatrick Lockwood-Taylor
CountryIreland
Healthcare
Drug Manufacturers - Specialty & Generic
Next EarningsMay 6, 2026 · In 1 weekBefore Market Open · Q1 2026
Financials
Perrigo Company FAQ
Common questions about Perrigo Company
Perrigo Company is scheduled to report earnings for Q1 2026 on May 6, 2026 before market open. Analysts estimate revenue of $1.0B.